Active Surveillance Use for Prostate Cancer More Than Tripled Since 2005

Source Summary

A large study of veterans found that active surveillance for low- and favorable intermediate-risk prostate cancer increased from 27% in 2005 to more than triple that rate, reflecting a significant shift in treatment approach for early-stage prostate cancer.